Caroline Dorsa - Net Worth and Insider Trading

Caroline Dorsa Net Worth

The estimated net worth of Caroline Dorsa is at least $11 Million dollars as of 2024-03-19. Caroline Dorsa is the Executive VP & CFO of Public Service Enterprise Group Inc and owns about 110,995 shares of Public Service Enterprise Group Inc (PEG) stock worth over $7 Million. Caroline Dorsa is the Director of Biogen Inc and owns about 17,093 shares of Biogen Inc (BIIB) stock worth over $4 Million. Caroline Dorsa is also the Director of Intellia Therapeutics Inc and owns about 5,410 shares of Intellia Therapeutics Inc (NTLA) stock worth over $148,072. Details can be seen in Caroline Dorsa's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Caroline Dorsa has not made any transactions after 2021-04-05 and currently still holds the listed stock(s).

Transaction Summary of Caroline Dorsa

To

Caroline Dorsa Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Caroline Dorsa owns 8 companies in total, including Goldman Sachs MLP Income Opportunities Fund () , Intellia Therapeutics Inc () , and Biogen Inc () among others .

Click here to see the complete history of Caroline Dorsa’s form 4 insider trades.

Insider Ownership Summary of Caroline Dorsa

Ticker Comapny Transaction Date Type of Owner
Goldman Sachs MLP Income Opportunities Fund 2020-09-28 director
Intellia Therapeutics Inc 2021-04-05 director
Biogen Inc 2016-09-22 director
Illumina Inc 2017-01-26 director
Goldman Sachs MLP and Energy Renaissance Fund 2016-09-15 director
Public Service Enterprise Group Inc 2015-08-05 director
Gilead Sciences Inc 2007-11-05 SVP & Chief Financial Officer
Duke Energy Corp 2021-05-06 director

Caroline Dorsa Latest Holdings Summary

Caroline Dorsa currently owns a total of 3 stocks. Among these stocks, Caroline Dorsa owns 110,995 shares of Public Service Enterprise Group Inc (PEG) as of August 5, 2015, with a value of $7 Million and a weighting of 64.58%. Caroline Dorsa owns 17,093 shares of Biogen Inc (BIIB) as of September 22, 2016, with a value of $4 Million and a weighting of 34.08%. Caroline Dorsa also owns 5,410 shares of Intellia Therapeutics Inc (NTLA) as of April 5, 2021, with a value of $148,072 and a weighting of 1.35%.

Latest Holdings of Caroline Dorsa

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PEG Public Service Enterprise Group Inc 2015-08-05 110,995 64.03 7,107,010
BIIB Biogen Inc 2016-09-22 17,093 219.40 3,750,204
NTLA Intellia Therapeutics Inc 2021-04-05 5,410 27.37 148,072

Holding Weightings of Caroline Dorsa


Caroline Dorsa Form 4 Trading Tracker

According to the SEC Form 4 filings, Caroline Dorsa has made a total of 0 transactions in Public Service Enterprise Group Inc (PEG) over the past 5 years. The most-recent trade in Public Service Enterprise Group Inc is the sale of 20,528 shares on August 5, 2015, which brought Caroline Dorsa around $844,522.

According to the SEC Form 4 filings, Caroline Dorsa has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 27,570 shares on September 22, 2016, which brought Caroline Dorsa around $9 Million.

According to the SEC Form 4 filings, Caroline Dorsa has made a total of 1 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 7,500 shares on April 5, 2021, which brought Caroline Dorsa around $616,425.

Insider Trading History of Caroline Dorsa

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Caroline Dorsa Trading Performance

GuruFocus tracks the stock performance after each of Caroline Dorsa's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Caroline Dorsa is 8.27%. GuruFocus also compares Caroline Dorsa's trading performance to market benchmark return within the same time period. The performance of stocks bought by Caroline Dorsa within 3 months outperforms 10 times out of 13 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Caroline Dorsa's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Caroline Dorsa

Average Relative Return

61.29%

Average relative return per transaction

Outperforming Transactions

100%

13 out of 13 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 1.69 8.27 18.28 61.29 44.19 41.96
Relative Return to S&P 500(%) 2.14 5.69 8.27 43.6 32.14 28.43

Caroline Dorsa Ownership Network

Ownership Network List of Caroline Dorsa

No Data

Ownership Network Relation of Caroline Dorsa


Caroline Dorsa Owned Company Details

What does Goldman Sachs MLP Income Opportunities Fund do?

Who are the key executives at Goldman Sachs MLP Income Opportunities Fund?

Caroline Dorsa is the director of Goldman Sachs MLP Income Opportunities Fund. Other key executives at Goldman Sachs MLP Income Opportunities Fund include Principal Accounting Officer Joseph F Dimaria , other: Portfolio Manager Kyri Loupis , and Secretary Caroline Kraus .

Goldman Sachs MLP Income Opportunities Fund () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Goldman Sachs MLP Income Opportunities Fund () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Goldman Sachs MLP Income Opportunities Fund () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Goldman Sachs MLP Income Opportunities Fund ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Goldman Sachs MLP Income Opportunities Fund Insider Transactions

No Available Data

Caroline Dorsa Mailing Address

Above is the net worth, insider trading, and ownership report for Caroline Dorsa. You might contact Caroline Dorsa via mailing address: Biogen Inc., 225 Binney St., Cambridge Ma 02142.

Discussions on Caroline Dorsa

No discussions yet.